Skip to main content

Amed Ouattara, PhD, Dpharm

Academic Title:

Research Associate

Primary Appointment:

Medicine

Education and Training

Dr. Ouattara received his PharmD from the University of Bamako, Mali, and completed a Master of Sciences in medical parasitology in Mali and France in 2002. Dr. Ouattara received his Ph.D. in Molecular Epidemiology from the University Of Maryland School Of Medicine in 2012. Dr. Ouattara joined the Division of Malaria Research in 2015 after completing postdoctoral training at NIH and the University of Maryland.

Biosketch

Dr. Ouattara’s research interests include molecular epidemiology, population genetics, and vaccine design. His work focuses on using new approaches to prioritize malaria vaccine antigens candidates, assessing the strain-specific efficacy of malaria vaccines, and surveillance of “vaccine resistant malaria.” 

Research/Clinical Keywords

malaria, vaccine, diversity-coverage, population genetics

Highlighted Publications

1.   Amed Ouattara, Alyssa E. Barry, Sheetij Dutta, Edmond J. Remarque, James G. Beeso, Christopher V. Plowe. Designing malaria vaccines to circumvent antigen variability. Vaccine.  2015 Dec 22;33(52):7506-12. PMC4731100

2.   Amed Ouattara, Matthew B. Laurens.  Vaccines against Malaria. CID. 2015 Mar 15;60(6):930-6. PMC4357819.

3.   Amed Ouattara, Aminatou Kone, Matthew Adams, BakaryFofana, Amelia Walling Maiga, Shay Hampton, Nouhoum Diallo, Jose Pedro Gill, Anders Bjorkman, Ogobara K. Doumbo, Christopher V. Plowe, Abdoulaye A. Djimde. Polymorphisms in the K13-propeller proteins in artemisinin susceptible Plasmodium falciparum parasites from Bougoula-Hameau, Mali. Am J Trop Med Hyg. 2015 Apr 27. pii: 14-0605.

4.   Bailey JA, Pablo J, Niangaly A, Travassos MA, Ouattara A, Coulibaly D, Laurens MB, Takala-Harrison SL, Lyke KE, Skinner J, Berry AA, Jasinskas A, Nakajima-Sasaki R, Kouriba B, Thera MA, Felgner PL, Doumbo OK, Plowe CV. Seroreactivity to a Large Panel of Field-Derived Plasmodium falciparum Apical Membrane Antigen 1 and Merozoite Surface Protein 1 Variants Reflects Seasonal and Lifetime Acquired Responses to Malaria. Am. J. Trop. Med. Hyg. Oct 2014.

5.   Kavita Gandhi, Mahamadou A. Thera, Drissa Coulibaly, Karim Traore, Ando B. Guindo, Amed Ouattara, Shannon Takala-Harrison, Andrea A. Berry, Ogobara K. Doumbo, Christopher V. Plowe. Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications. PLoS One. 2014. 9(7): e101783.

6.   Matthew B. Laurens, Mahamadou A. Thera, Drissa Coulibaly, Amed Ouattara, Abdoulaye K. Kone, Ando B. Guindo, Karim Traore, Idrissa Traore, Bourema Kouriba, Dapa A. Diallo, Issa Diarra, Modibo Daou, Amagana Dolo, Youssouf Tolo, Mahamadou S. Sissoko, Amadou Niangaly, Mady Sissoko, Shannon Takala-Harrison, Kirsten E. Lyke, Yukun Wu, William C. Blackwelder, Olivier Godeaux, Johan Vekemans, Marie-Claude Dubois, W. Ripley Ballou, Joe Cohen, Tina Dube, Lorraine Soisson, Carter L. Diggs, Brent House, Jason W. Bennett, David E. Lanar, Sheetij Dutta, D. Gray Heppner, Christopher V. Plowe, Ogobara K. Doumbo Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in Malian children: 24-Month follow-up of a randomized, gouble-blinded phase 2 trial. PLoS One. 2013. 8(11): e79323.

7.   Ouattara A, Takala Harrison S, Thera MA,  Coulibaly D, Niangaly A, Saye R, Tolo Y, Dutta S, Heppner GD, Soisson L, Diggs CL, Vekemans J, Cohen J, Leach A, Blackwelder WC, Dube T, Laurens MB, Doumbo OK, Plowe CV. Molecular Basis of Strain-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications. JID. 2013. 207(3): 511-519.

8. Ouattara A, Mu J, Takala-Harrison S, Saye R, Sagara I, Dicko A, Niangaly A, Duan J, Ellis RD, Miller LH, Su XZ, Plowe CV, Doumbo OK. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malar. J. June 2010; 9(1):175.